4.6 Article

DNA damage response activation in mouse embryonic fibroblasts undergoing replicative senescence and following spontaneous immortalization

期刊

CELL CYCLE
卷 7, 期 22, 页码 3601-3606

出版社

TAYLOR & FRANCIS INC
DOI: 10.4161/cc.7.22.7152

关键词

cellular senescence; mouse embryo fibroblasts (MEFs); DNA damage response (DDR); ataxia-telangiectasia mutated (ATM); oxidative stress

资金

  1. IFOM-IEO
  2. Associazione Italiana per la Ricerca sul Cancro (AIRC)
  3. Association for International Cancer Research (AICR)
  4. Human Frontier Science Program (HFSP)
  5. European Union
  6. EMBO Young Investigator Program (YIP)

向作者/读者索取更多资源

Primary mouse embryonic fibroblasts (MEFs) are a popular tool for molecular and cell biology studies. However, when MEFs are grown in vitro under standard tissue culture conditions, they proliferate only for a limited number of population doublings (PD) and eventually undergo cellular senescence. Presently, the molecular mechanisms halting cell cycle progression and establishing cellular senescence under these conditions are unclear. Here, we show that a robust DNA damage response (DDR) is activated when MEFs undergo replicative cellular senescence. Senescent cells accumulate senescence-associated DDR foci (SDFs) containing the activated form of ATM, its phosphorylated substrates and gamma H2AX. In senescent MEFs, DDR markers do not preferentially accumulate at telomeres, the end of linear chromosomes. It has been observed that proliferation of MEFs is extended if they are cultured at low oxygen tension (3% O-2). We observed that under these conditions, DDR is not observed and senescence is not established. Importantly, inactivation of ATM in senescent MEFs allows escape from senescence and progression through the S-phase. Therefore, MEFs undergoing cellular senescence arrest their proliferation due to the activation of a DNA damage checkpoint mediated by ATM kinase. Finally, we observed that spontaneously immortalized proliferating MEFs display markers of an activated DDR, indicating the presence of chromosomal DNA damage in these established cell lines.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Biochemistry & Molecular Biology

DNA damage response at telomeres boosts the transcription of SARS-CoV-2 receptor ACE2 during aging

Sara Sepe, Francesca Rossiello, Valeria Cancila, Fabio Iannelli, Valentina Matti, Giada Cicio, Matteo Cabrini, Eugenia Marinelli, Busola R. Alabi, Alessia di Lillo, Arianna Di Napoli, Jerry W. Shay, Claudio Tripodo, Fabrizio d'Adda di Fagagna

Summary: As individuals age, the expression of ACE2 in the lungs increases, making elderly individuals more susceptible to SARS-CoV-2. Telomere damage triggers DDR activation, leading to an upregulation of ACE2 and potentially increasing susceptibility to infection in the elderly.

EMBO REPORTS (2022)

Article Oncology

Targeting mitochondrial respiration and the BCL2 family in high-grade MYC-associated B-cell lymphoma

Giulio Donati, Micol Rava, Marco Filipuzzi, Paola Nicoli, Laura Cassina, Alessandro Verrecchia, Mirko Doni, Simona Rodighiero, Federica Parodi, Alessandra Boletta, Christopher P. Vellano, Joseph R. Marszalek, Giulio F. Draetta, Bruno Amati

Summary: MYC activity is closely correlated with gene expression signatures related to oxidative phosphorylation in DLBCL, sensitizing B cells to the ETC complex I inhibitor IACS-010759. The combination of BCL2 inhibitor venetoclax and IACS-010759 showed synergy in DHL with concurrent activation of MYC and BCL2, while in BCL2-negative lymphoma cells, the Mcl-1 inhibitor S63845 potentiated killing by IACS-010759. This suggests a novel therapeutic approach against aggressive, MYC-associated DLBCL variants.

MOLECULAR ONCOLOGY (2022)

Review Cell Biology

Telomere dysfunction in ageing and age-related diseases

Francesca Rossiello, Diana Jurk, Joao F. Passos, Fabrizio D'Adda di Fagagna

Summary: The article reviews the impact of telomere shortening and dysfunction on aging and a variety of age-related diseases in humans. Accumulation of senescent cells in aging organisms is believed to contribute to bodily dysfunction. Telomere shortening and damage are known causes of cellular senescence and aging. The authors argue that telomeric dysfunction plays a broad role in human pathologies associated with normal aging.

NATURE CELL BIOLOGY (2022)

Article Multidisciplinary Sciences

BRCA1 deficiency specific base substitution mutagenesis is dependent on translesion synthesis and regulated by 53BP1

Dan Chen, Judit Z. Gervai, Adam Poti, Eszter Nemeth, Zoltan Szeltner, Bernadett Szikriszt, Zsolt Gyure, Judit Zamborszky, Marta Ceccon, Fabrizio d'Adda di Fagagna, Zoltan Szallasi, Andrea L. Richardson, David Szuts

Summary: Defects in BRCA1, BRCA2, and other genes involved in DNA repair have been found to increase the rate of mutagenesis. This study reveals that Y family translesion synthesis (TLS) polymerases play a role in the generation of spontaneous mutations in BRCA1 deficient cells. Furthermore, the protein 53BP1 regulates TLS and template switching in replicative DNA damage bypass.

NATURE COMMUNICATIONS (2022)

Review Oncology

Single-Cell Technologies to Decipher the Immune Microenvironment in Myeloid Neoplasms: Perspectives and Opportunities

Chiara Caprioli, Iman Nazari, Sara Milovanovic, Pier Giuseppe Pelicci

Summary: Single-cell technologies offer valuable insights into the development and therapeutic resistance mechanisms of myeloid neoplasms, enabling the development of more efficient immunotherapies.

FRONTIERS IN ONCOLOGY (2022)

Article Biology

Polycomb group ring finger protein 6 suppresses Myc-induced lymphomagenesis

Nina Tanaskovic, Mattia Dalsass, Marco Filipuzzi, Giorgia Ceccotti, Alessandro Verrecchia, Paola Nicoli, Mirko Doni, Daniela Olivero, Diego Pasini, Haruhiko Koseki, Arianna Sabo, Andrea Bisso, Bruno Amati

Summary: Loss of Mga and PRC1.6 has no significant impact on Myc-induced lymphomagenesis in transgenic mice, but loss of Pcgf6 accelerates tumor formation. This suggests an unexpected tumor suppressor activity of Pcgf6 independent of Mga and PRC1.6.

LIFE SCIENCE ALLIANCE (2022)

Article Biochemistry & Molecular Biology

Aberrant activation of p53/p66Shc-mInsc axis increases asymmetric divisions and attenuates proliferation of aged mammary stem cells

Chiara Priami, Daniela Montariello, Giulia De Michele, Federica Ruscitto, Andrea Polazzi, Simona Ronzoni, Giovanni Bertalot, Giorgio Binelli, Valentina Gambino, Lucilla Luzi, Marina Mapelli, Marco Giorgio, Enrica Migliaccio, Pier Giuseppe Pelicci

Summary: Aging is characterized by a decline in tissue regenerative capacity and resident stem cell function. This study reveals that p66Shc plays a crucial role in mammary gland aging by inducing p53/p44 signaling, leading to decreased symmetric divisions, reduced proliferation and regenerative potential of mammary stem cells.

CELL DEATH AND DIFFERENTIATION (2022)

Article Oncology

Hematological disorders after salvage PARPi treatment for ovarian cancer: Cytogenetic and molecular defects and clinical outcomes

Elisabetta Todisco, Federica Gigli, Chiara Ronchini, Viviana Amato, Simona Sammassimo, Rocco Pastano, Gabriella Parma, Maria Teresa Lapresa, Francesco Bertolini, Chiara Corsini, Giuliana Gregato, Claudia Poletti, Pier Giuseppe Pelicci, Myriam Alcalay, Nicoletta Colombo, Corrado Tarella

Summary: In this study, it was found that EOC patients undergoing chemotherapy and prolonged PARPi therapy are at risk of developing therapy-related myeloid neoplasms (t-MNs), with poor outcomes and high mortality rates. Careful diagnostic procedures are strongly recommended for patients experiencing unusual cytopenias during PARPi therapy.

INTERNATIONAL JOURNAL OF CANCER (2022)

Review Biochemistry & Molecular Biology

Beyond Genetics: Metastasis as an Adaptive Response in Breast Cancer

Federica Ruscitto, Niccolo Roda, Chiara Priami, Enrica Migliaccio, Pier Giuseppe Pelicci

Summary: This review examines the classification, epidemiology, and impact of metastatic disease on prognosis and survival in breast cancer. The authors discuss the genetic and phenotypic heterogeneity of breast tumors, as well as the mechanisms underlying adaptive stress responses during metastatic progression.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Correction Oncology

Single-cell technologies to decipher the immune microenvironment in myeloid neoplasms: Perspectives and opportunities (vol 11, 796477, 2022)

Chiara Caprioli, Iman Nazari, Sara Milovanovic, Pier Giuseppe Pelicci

FRONTIERS IN ONCOLOGY (2022)

Article Oncology

Quantifying geographical accessibility to cancer clinical trials in different income landscapes

G. Tini, D. Trapani, B. A. Duso, P. Beria, G. Curigliano, P. G. Pelicci, L. Mazzarella

Summary: This study developed a distance-based accessibility index to assess the accessibility of clinical trials and analyzed the inequalities across countries and regions. The study found that the accessibility of clinical trials is unevenly distributed, especially in high-income and upper-middle-income countries. Although the accessibility increased over time, it did not keep pace with the increase in the number of trials.

ESMO OPEN (2022)

Article Biophysics

Alterations induced by the PML-RARa oncogene revealed by image cross correlation spectroscopy

Elena Cerutti, Morgana D'Amico, Isotta Cainero, Pier Giuseppe Pelicci, Mario Faretta, Gaetano Ivan Dellino, Alberto Diaspro, Luca Lanzano

Summary: The molecular mechanisms of oncogene-induced genomic damage are still poorly understood. This study combines superresolution microscopy with image cross correlation spectroscopy to quantify alterations induced by the PML-RARa oncogene in an in vitro model of acute promyelocytic leukemia. The results demonstrate that activation of the oncogene leads to an increase in the fraction of transcription sites colocalized with PML/PML-RARa, resulting from the disruption of physiological PML bodies and the occurrence of PML-RARa microspeckles. The study also reveals a heterogeneous response of cells to the activation of the oncogene.

BIOPHYSICAL JOURNAL (2022)

Article Biochemistry & Molecular Biology

From Double-Strand Break Recognition to Cell-Cycle Checkpoint Activation: High Content and Resolution Image Cytometry Unmasks 53BP1 Multiple Roles in DNA Damage Response and p53 Action

Laura Furia, Simone Pelicci, Mirco Scanarini, Pier Giuseppe Pelicci, Mario Faretta

Summary: 53BP1 protein plays an important role in sustaining the activity of the p53-regulated transcriptional program. This study uses an automated-microscopy protocol to analyze the evolution of the DNA-Damage Response (DDR) and demonstrates the movement of 53BP1 protein from damaged sites to the nucleoplasm, where it interacts with p53 and enhances the transcriptional regulation of the guardian of the genome protein.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Article Medicine, Research & Experimental

Oxidative stress enhances the therapeutic action of a respiratory inhibitor in MYC-driven lymphoma

Giulio Donati, Paola Nicoli, Alessandro Verrecchia, Veronica Vallelonga, Ottavio Croci, Simona Rodighiero, Matteo Audano, Laura Cassina, Aya Ghsein, Giorgio Binelli, Alessandra Boletta, Nico Mitro, Bruno Amati

Summary: MYC is a key driver in multiple tumor types and can be targeted by drugs that suppress mitochondrial respiration. In this study, the mechanistic basis for the lethal interaction between MYC and respiratory complex I inhibitor IACS-010759 was unraveled. It was found that high-dose ascorbate synergized with IACS-010759 to kill MYC-overexpressing cells and improved therapeutic outcomes in B-cell lymphoma xenografts.

EMBO MOLECULAR MEDICINE (2023)

Article Biology

High-resolution Nanopore methylome-maps reveal random hyper-methylation at CpG-poor regions as driver of chemoresistance in leukemias

Alberto Magi, Gianluca Mattei, Alessandra Mingrino, Chiara Caprioli, Chiara Ronchini, GianMaria Frige, Roberto Semeraro, Davide Bolognini, Alessandro Rambaldi, Anna Candoni, Emanuela Colombo, Luca Mazzarella, Pier Giuseppe Pelicci

Summary: DNA methylation patterns in sparse CpG regions drive chemoresistance in Acute Myeloid Leukemia patients.

COMMUNICATIONS BIOLOGY (2023)

暂无数据